Vyome

HINDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$14.739 M

$2.10 +7.14%

Close of 18 Sept 2026

Revenue

$319.7K

#3553 by revenue

Earnings

-$10.3M

Loss-making

Shares outstanding

7,018,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#410Lisata TherapeuticsLSTA$15.3M
#411Moleculin BiotechMBRX$15.1M
#412VyomeHIND$14.7M
#413Quoin PharmaceuticalsQNRX$14.2M
#414EnlivexENLV$14.1M

What if Vyome were worth as much as…

Open the what-if tool →

Gold $30.4T

$4,329,606

Per share 2,061,717× higher

Bitcoin $1.64T

$233,101.28

Per share 111,001× higher

Nvidia $5.36T

$763,223.70

Per share 363,440× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Vyome are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.